A relatively low-tech stock trade is making Tesla Inc.’s dizzying rally look like an under-performance.

Brings Together Highly Complementary Portfolios to Empower Clinicians and Patients in the Fight Against Cancer
Establishes Integrated Platform of End-to-End Oncology Solutions to Address Entire Cancer Care Continuum – from Screening and Diagnosis to Care Delivery and Post-Treatment Survivorship
Creates a Leading Digital Healthcare Platform that Leverages Real-World Evidence and AI, Positioning Combined Company to Favorably Disrupt Oncology Care with Software, Data and Technology
Varian Shareholders to Receive $177.50 per Share in Cash, Representing a 42% Premium

The immune systems of mammals – including humans – might struggle to detect and respond to germs from other planets, new research suggests.

Britain has signed deals to secure 90 million doses of two possible COVID-19 vaccines from an alliance of Pfizer Inc (PFE.N) and BioNTech (22UAy.F), and French group Valneva (VLS.PA), the business ministry said on Monday.